BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 120,000 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of C$2.93, for a total transaction of C$351,600.00.
BioRem Stock Up 1.4 %
CVE:BRM opened at C$2.97 on Wednesday. BioRem Inc. has a 1 year low of C$0.88 and a 1 year high of C$3.39. The stock has a 50-day moving average price of C$2.68 and a two-hundred day moving average price of C$2.32. The stock has a market cap of C$46.63 million, a price-to-earnings ratio of 14.14 and a beta of 0.85. The company has a current ratio of 1.57, a quick ratio of 1.08 and a debt-to-equity ratio of 48.97.
About BioRem
Recommended Stories
- Five stocks we like better than BioRem
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What is the Hang Seng index?
- Netflix Is On Track To Hit $1,000 By Christmas
- What Do S&P 500 Stocks Tell Investors About the Market?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.